Agendas
8:30 AM — 9:30 AM
Session 0402 Application of Bayesian Methods for Clinical Trials8:30 AM — 9:30 AM
Session 0502 Effective Risk Management8:30 AM — 9:30 AM
Session 0505 Post Marketing Safety Surveillance8:30 AM — 9:30 AM
Session 0602 Managing Post-Approval CMC Changes in China and the US - II8:30 AM — 9:30 AM
Session 0605 ChP Townhall8:30 AM — 9:30 AM
Session 0705 Detection and Evaluation of Immunogenicity of Biologics8:30 AM — 9:30 AM
Session 1004 Newer Than New-Innovations to Create New Health Solutions1:30 PM — 5:30 PM
Opening Plenary Session8:30 AM — 10:00 AM
INNOVATION: WHY SHOULD I CARE?8:30 AM — 10:00 AM
PATIENT AND THERAPEUTIC CENTRIC CLINICAL MATERIALS8:30 AM — 10:00 AM
RISK BASED SAFETY MONITORING8:30 AM — 10:00 AM
Session 0301 The Responsibilities to Speed Up Clinical Trials8:30 AM — 10:00 AM
Session 0401 Statistical Methods for Oncology Clinical Trials8:30 AM — 10:00 AM
Session 0601 Managing Post-Approval CMC Changes in China and the US - I8:30 AM — 10:00 AM
Session 0701 New Trend/Technology in Biologic Development8:30 AM — 10:00 AM
Session 0801 Breakthrough by Innovative Disease Therapies10:30 AM — 12:00 PM
CFDA Townhall10:30 AM — 12:00 PM
Session 0702 Safety Evaluation of New Types of Antibodies1:30 PM — 3:00 PM
Session 0803 Breakthrough Therapies in Diabetes Diseases8:30 AM — 10:00 AM
PARTNERSHIP STRATEGIES AND CREATIVE FRAMEWORKS IN THE NEW ERA8:30 AM — 10:00 AM
Session 0105 How Far Away is the Innovative Medicine to China Patients? - I8:30 AM — 10:00 AM
Session 0305 Clinical Science - I - Development Strategy8:30 AM — 10:00 AM
Session 0405 Evolving CDM Role in Clinical Trials10:30 AM — 12:00 PM
Session 0106 How Far Away is the Innovative Medicine to China Patients? - II10:30 AM — 12:00 PM
Session 0406 Quality and Integrity of Clinical Trial Data10:30 AM — 12:00 PM
Session 0506 Active Safety Surveillance10:30 AM — 12:00 PM
Session 1206 On the Way - China Innovative Pharmaceutical Company10:30 AM — 12:00 PM
Special Session Brain Storm - Discussion in Depth of China SMO Practice1:30 PM — 5:30 PM
GENERIC DRUG FORUM (PART IV)1:30 PM — 3:00 PM
Session 0307 Clinical Operation - Risk Based Monitoring1:30 PM — 3:00 PM
Session 0507 Vaccine Safety and Risk Management1:30 PM — 3:00 PM
Session 0907 Site Management & SMO3:30 PM — 5:00 PM
Session 0308 Project Management - Study Wide3:30 PM — 5:00 PM
Session 0508 Herbs Safety3:30 PM — 5:00 PM
Session 0908 Internationalization of Chinese CRO in chinaHave an account?